{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:49:50Z","timestamp":1791078590761,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008382","name":"Fundo Regional para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/28252\/2006"],"award-info":[{"award-number":["SFRH\/BPD\/28252\/2006"]}],"id":[{"id":"10.13039\/100008382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI071183"],"award-info":[{"award-number":["PI071183"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.nbd.2009.08.012","type":"journal-article","created":{"date-parts":[[2009,9,5]],"date-time":"2009-09-05T05:11:43Z","timestamp":1252127503000},"page":"461-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: Role in excitotoxicity"],"prefix":"10.1016","volume":"36","author":[{"given":"Xavier","family":"Xifr\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Garc\u00eda-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"D\u00edaz-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 J.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Alberch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"P\u00e9rez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2009.08.012_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.nbd.2004.07.002","article-title":"FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures","volume":"17","author":"Almeida","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2009.08.012_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-5793(96)00959-3","article-title":"Calcineurin and mitochondrial function in glutamate-induced neuronal cell death","volume":"394","author":"Ankarcrona","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2009.08.012_bib3","doi-asserted-by":"crossref","first-page":"34450","DOI":"10.1074\/jbc.274.48.34450","article-title":"High level calcineurin activity predisposes neuronal cells to apoptosis","volume":"274","author":"Asai","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.08.012_bib4","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1073\/pnas.93.10.5037","article-title":"Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin","volume":"93","author":"Bao","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.08.012_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2009.08.012_bib6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0022-3565(24)38002-4","article-title":"Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic\/reperfusion injury","volume":"288","author":"Bochelen","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2009.08.012_bib7","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.08.012_bib8","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.08.012_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington's disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2009.08.012_bib10","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.90.21.9808","article-title":"Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity","volume":"90","author":"Dawson","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.08.012_bib11","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1523\/JNEUROSCI.3183-05.2005","article-title":"Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease","volume":"25","author":"Diaz-Hernandez","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.08.012_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/368147a0","article-title":"Mice lacking brain-derived neurotrophic factor develop with sensory deficits","volume":"368","author":"Ernfors","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2009.08.012_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2009.08.012_bib14","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1046\/j.1471-4159.2003.01794.x","article-title":"Cyclosporin A prevents calpain activation despite increased intracellular calcium concentrations, as well as translocation of apoptosis-inducing factor, cytochrome c and caspase-3 activation in neurons exposed to transient hypoglycemia","volume":"85","author":"Ferrand-Drake","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.08.012_bib15","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","article-title":"Calpain activation in Huntington's disease","volume":"22","author":"Gafni","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.08.012_bib16","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","article-title":"Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression","volume":"158","author":"Giralt","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2009.08.012_bib17","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.5473-08.2009","article-title":"Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease","volume":"29","author":"Graham","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.08.012_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/343369a0","article-title":"Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices","volume":"343","author":"Halpain","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2009.08.012_bib19","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.08.012_bib20","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2009.08.012_bib21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.brainresbull.2006.03.013","article-title":"Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation","volume":"69","author":"Hernandez-Espinosa","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2009.08.012_bib22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2009.08.012_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2009.08.012_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/brain\/awh058","article-title":"Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model","volume":"127","author":"Jarabek","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2009.08.012_bib25","doi-asserted-by":"crossref","first-page":"13367","DOI":"10.1074\/jbc.273.22.13367","article-title":"Regulation of the calmodulin-stimulated protein phosphatase, calcineurin","volume":"273","author":"Klee","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.08.012_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington's disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2009.08.012_bib27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1006\/mcne.2002.1152","article-title":"Abnormal phosphorylation of synapsin I predicts a neuronal transmission impairment in the R6\/2 Huntington's disease transgenic mice","volume":"20","author":"Lievens","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2009.08.012_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2009.08.012_bib29","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1523\/JNEUROSCI.3706-05.2006","article-title":"Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421","volume":"26","author":"Pardo","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.08.012_bib30","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1046\/j.1471-4159.2000.0752190.x","article-title":"Brain-Derived Neurotrophic factor, neurotrophin-3, and neurotrophin-4\/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease","volume":"75","author":"Perez-Navarro","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.08.012_bib31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1471-4159.2004.02904.x","article-title":"Brain-derived neurotrophic factor prevents changes in Bcl-2 family members and caspase-3 activation induced by excitotoxicity in the striatum","volume":"92","author":"Perez-Navarro","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.08.012_bib32","first-page":"1217","article-title":"Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease","volume":"21","author":"Perez-Navarro","year":"2006","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.nbd.2009.08.012_bib33","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.08.012_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0014-2999(00)00584-7","article-title":"Cyclosporin A targets involved in protection against glutamate excitotoxicity","volume":"404","author":"Ruiz","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2009.08.012_bib35","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1152\/physrev.2000.80.4.1483","article-title":"Calcineurin: form and function","volume":"80","author":"Rusnak","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2009.08.012_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0006-8993(96)01387-X","article-title":"Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration","volume":"751","author":"Schmued","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2009.08.012_bib37","doi-asserted-by":"crossref","first-page":"42290","DOI":"10.1074\/jbc.M505804200","article-title":"Death-associated protein kinase is activated by dephosphorylation in response to cerebral ischemia","volume":"280","author":"Shamloo","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.08.012_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0379-0738(96)01981-0","article-title":"Involvement of calpain in postmortem proteolysis in the rat brain","volume":"81","author":"Sorimachi","year":"1996","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.nbd.2009.08.012_bib39","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1523\/JNEUROSCI.20-19-07246.2000","article-title":"Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury","volume":"20","author":"Springer","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.08.012_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0014-5793(82)80319-0","article-title":"Discovery of a Ca2+-and calmodulin-dependent protein phosphatase: probable identity with calcineurin (CaM-BP80)","volume":"137","author":"Stewart","year":"1982","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2009.08.012_bib41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2009.08.012_bib42","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1021\/bi00406a059","article-title":"Activation of a calmodulin-dependent phosphatase by a Ca2+-dependent protease","volume":"27","author":"Tallant","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2009.08.012_bib43","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1471-4159.2003.02098.x","article-title":"Inhibition of excitatory neuronal cell death by cell-permeable calcineurin autoinhibitory peptide","volume":"87","author":"Terada","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.08.012_bib44","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2009.08.012_bib45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nbd.2007.10.003","article-title":"Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling","volume":"29","author":"Torres-Peraza","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2009.08.012_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/nbdi.2002.0514","article-title":"Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition","volume":"10","author":"Uchino","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2009.08.012_bib47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.08.012_bib48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.284.5412.339","article-title":"Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD","volume":"284","author":"Wang","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.nbd.2009.08.012_bib49","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1074\/jbc.M309767200","article-title":"Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration","volume":"279","author":"Wu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.08.012_bib50","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1471-4159.2008.05252.x","article-title":"Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells","volume":"105","author":"Xifro","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.08.012_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2009.08.012_bib52","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","article-title":"Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease","volume":"23","author":"Yu","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.08.012_bib53","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1523\/JNEUROSCI.4424-03.2004","article-title":"Calmodulin regulates transglutaminase 2 cross-linking of huntingtin","volume":"24","author":"Zainelli","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.08.012_bib54","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2009.08.012_bib55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.cdd.4402261","article-title":"Mutant huntingtin can paradoxically protect neurons from death","volume":"15","author":"Zuchner","year":"2008","journal-title":"Cell Death Differ"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109002393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109002393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:04:48Z","timestamp":1760850288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996109002393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0969996109002393"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2009.08.012","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: Role in excitotoxicity","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2009.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}